Page 170 - 2022 Ranger Medic Handbook
P. 170

GATAFLOXACIN OPHTHALMIC (ZYMAR)
         Class: Antimicrobial – antibiotic, ocular fluoroquinolone
         Dose: Days 1 and 2: instill 1 drop in affected eye(s) q2hr while awake, up to 8 × daily. Days 3–7: Instill 1 drop in affected
         eye(s) up to 4 times/day while awake. To instill in eye, tilt head back, place medication in conjunctival sac and close
         eye(s). Apply light finger pressure on lacrimal sac for 1 minute following instillation. To avoid bottle contamination, do
         not touch tip of container to any surface. Replace cap after use
         Indications: Eye infections
         Contraindications: Hypersensitivity to any component of product, pregnancy category may use during pregnancy
         and while breastfeeding
         Adverse/Side-effects: Upon instillation, may cause temporary blurring of vision or stinging. If stinging, burning, or
         itching becomes pronounced, or redness, irritation, swelling, decreasing vision, or pain persists or worsens, discon-
         tinue and consider alternative therapy. Lid margin crusting, white crystalline precipitates, and foreign body sensation
         in the eye have been reported. Bad/bitter taste in mouth, nausea, discontinue at first sign of skin rash or other allergic
         reaction, corneal staining, tearing and photophobia
         Interactions: When gatifloxacin is absorbed into the bloodstream, there may be an interaction between gatifloxacin
    SECTION 4  ■ ■    antacids (containing aluminum, calcium, and magnesium)
         and any of the following:
             digoxin
         ■    probenecid
         ■    vitamins (containing zinc, calcium, magnesium, or iron)
         Mission Impact: Aviation personnel are grounded for the initial 24 hours of antibiotic therapy and until the medical
         condition no longer interferes with safely performing aviation duties and the patient is free of side-effects

         GUAIFENESIN
         Class: ENT agent – antitussive, expectorant
         Action: Enhances reflex outflow of respiratory tract fluids by irritation of gastric mucosa; aids in expectoration by
         reducing adhesiveness and surface tension of secretions
         Dose: 100–400mg PO q4hr or 600–1,200mg XR PO q12hr (max: 2.4g/d)
         Indications: Relief of dry, nonproductive coughs associated with colds and bronchitis
         Contraindications: Guaifenesin hypersensitivity; pregnancy category may use during pregnancy and caution advised
         while breastfeeding
         Adverse/Side-effects: Low incidence of nausea; drowsiness
         Interactions: By inhibiting platelet function, may increase risk of bleeding in patients receiving heparin

         HYDROCORTISONE CREAM
         Class: Skin and mucous membrane agent – synthetic hormone; adrenal corticosteroid, glucocorticoid, mineralocorti-
         coid, anti-inflammatory
         Action: Stabilizes leukocyte lysosomal membranes, inhibits phagocytosis and release of allergic substances, sup-
         presses fibroblast formation and collagen deposition
         Dose: Topically AAA qd–qid
         Indications: To reduce inflammation in various skin conditions
         Contraindications: Steroid hypersensitivity, viral or bacterial diseases of skin; varicella or vaccinia on surfaces with
         compromised circulation; pregnancy category caution advised during pregnancy and while breastfeeding
         Adverse/Side-effects: Anaphylactoid reaction, aggravation or masking of infections, skin thinning and atrophy, acne,
         impaired wound healing, petechiae, ecchymosis, easy bruising, hypopigmentation or hyperpigmentation, hirsutism,
         acneiform eruptions, subcutaneous fat atrophy, allergic dermatitis, urticaria, angioneurotic edema, increased sweating
         Interactions: Estrogens potentiate effects; immune response to vaccines may be decreased

        156      SECTION 4   RANGER MEDIC PHARMACOLOGY & FORMULARY
   165   166   167   168   169   170   171   172   173   174   175